Fig 1: Effects of caspase recruitment domain family member 9 (CARD9) knockdown on esophageal squamous cell carcinoma (ESCC) cell proliferation and migration. ESCC cell lines (TE8 and T.Tn) were transfected with control siRNA or siCARD9. Relative CARD9 mRNA expression in ESCC cell lines after transfection of control siRNA and siCARD9 (A), and results of the proliferation assay (B) and migration assay (C) are shown. *P < .050
Fig 2: Immunohistochemical analysis of caspase recruitment domain family member 9 (CARD9) expression in esophageal squamous cell carcinoma. Images of high CARD9 expression (A and B), low CARD9 expression (C and D) and normal esophageal tissue (E and F) are shown (magnification ×100 in the upper section, ×400 in the lower section)
Fig 3: Comparisons of overall survival (OS) (A) and disease-free survival (DFS) (B) of high- and low-caspase recruitment domain family member 9 (CARD9) expression groups of patients with esophageal squamous cell carcinoma (ESCC). OS of high- and low-CARD9 expression groups in ESCC sorted by gender (C)
Supplier Page from Abcam for Anti-CARD9 antibody